MedPath

Biomad AS

Ownership
Private
Employees
-
Market Cap
-
Website

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Phase 3
Conditions
Sars-cov-2
Interventions
First Posted Date
2022-02-03
Last Posted Date
2022-03-17
Lead Sponsor
Biomad AS
Target Recruit Count
3000
Registration Number
NCT05222425
Locations
🇮🇶

Directorate of health of Sulaimani, Iraq -KRG, Sulaymaniyah, Iraq

Treatment of Covid-19 With a Herbal Compound, Xagrotin

Phase 1
Completed
Conditions
Covid19
Interventions
Combination Product: Xagrotin
First Posted Date
2021-08-24
Last Posted Date
2021-12-02
Lead Sponsor
Biomad AS
Target Recruit Count
661
Registration Number
NCT05017493
Locations
🇮🇶

Directorate of health of Sulaimani, Iraq -KRG, Sulaymaniyah, Iraq

© Copyright 2025. All Rights Reserved by MedPath